The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients Z Calikusu, Y Yildirim, Z Akcali, H Sakalli, N Bal, I Unal, O Ozyilkan Journal of Experimental & Clinical Cancer Research 28, 1-6, 2009 | 48 | 2009 |
Management of neuroendocrine carcinomas of the breast: A rare entity Y Yildirim, S Elagoz, A Koyuncu, C Aydin, K Karadayi Oncology letters 2 (5), 887-890, 2011 | 44 | 2011 |
Serum neopterin levels in patients with breast cancer Y Yildirim, N Gunel, U Coskun, H Pasaoglu, S Aslan, A Cetin Medical Oncology 25, 403-407, 2008 | 30 | 2008 |
Primary mediastinal yolk sac tumor in a 66-year-old woman U Coskun, N Günel, Y Yildirim, L Memis, ZM Boyacıoglu Medical Principles and Practice 11 (4), 218-220, 2002 | 30 | 2002 |
Signet-ring cell carcinoma of the gallbladder: a case report Z Karabulut, Y Yildirim, I Abaci, D Ilgici, O Ozyilkan Advances in therapy 25, 520-523, 2008 | 29 | 2008 |
Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer. U Coskun, N Gunel, E Onuk, E Yilmaz, O Bayram, D Yamac, A Cihan, ... Neoplasma 50 (3), 210-216, 2003 | 27 | 2003 |
Early diagnosis of cancer in renal transplant patients: a single center experience Y Yildirim, O Ozyilkan, R Emiroglu, B Demirhan, H Karakayali, M Haberal Asian Pacific Journal of Cancer Prevention 7 (2), 336, 2006 | 26 | 2006 |
Drug interaction between capecitabine and warfarin: a case report and review of the Y Yildirim, O Ozyilkan, Z Akcali, B Basturk International journal of clinical pharmacology and therapeutics 44 (2), 80-82, 2006 | 25 | 2006 |
Serum big endothelin-1 levels in female patients with breast cancer Y Yildirim, N Gunel, U Coskun, B Sancak, N Bukan, S Aslan, A Cetin International immunopharmacology 8 (8), 1119-1123, 2008 | 21 | 2008 |
Lack of influence of cyclooxygenese-2 expression in hepatocellular carcinomas on patient survival Y Yildirim, O Ozyilkan, B Bilezikci, Z Akcali, M Haberal Asian Pac J Cancer Prev 9 (2), 295-298, 2008 | 20 | 2008 |
No association between serum levels of insulin‐like growth factor‐I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma … B Sancak, U Coskun, N Gunel, E Onuk, A Cihan, A Karamercan, ... Internal medicine journal 34 (6), 310-315, 2004 | 20 | 2004 |
Prostate small cell carcinoma and skin metastases: a rare entity Y Yildirim, Y Akcay, O Ozyilkan, B Celasun medical principles and practice 17 (3), 250-252, 2008 | 19 | 2008 |
Primary squamous cell carcinoma of the stomach a case report Y Yildirim, Z Akcali, B Bilezikci, O Ozyilkan Tumori Journal 91 (5), 440-442, 2005 | 18 | 2005 |
Thromboembolic complications of cancer and management Y Yıldırım, Ö Özyılkan Acta Oncologica Turcica 42 (2), 86-91, 2009 | 11 | 2009 |
Hepatosellüler karsinomda tedavi yaklaşımları Y Yıldırım, Ö Özyılkan, H Karakayalı, M Haberal Hematoloji Onkoloji Dergisi, 18, 4, 248-253, 2008 | 8 | 2008 |
Signet-ring cell carcinoma of the colon with leptomeningeal involvement Y Yildirim, Z Akcali, O Ozyilkan Journal of Clinical Neuroscience 17 (8), 1051-1053, 2010 | 7 | 2010 |
Prognostic significance of the C-erbB-2 expression in Turkish non-small cell lung cancer patients Z Calikusu, Y Yildirim, Z Akcali, H Sakalli, N Bal, O Ozyilkan Asian Pac J Cancer Prev 10 (3), 479-482, 2009 | 7 | 2009 |
Kikuchi-fujimoto hastalığı U COŞKUN, Y YILDIRIM, K CEYHAN, S EREKUL, N GÜNEL Turkiye Klinikleri Journal of Medical Sciences 24 (1), 106-108, 2004 | 5 | 2004 |
Kanserin tromboembolik komplikasyonları ve tedaviye yönelik yaklaşımlar Y YILDIRIM, Ö ÖZYILKAN Acta Oncologica Turcica 42 (2), 86-91, 0 | 5 | |
Gemcitabine induced pulmonary injury U Coskun, N Gunel, Y Yildirim American Journal of Case Reports 5, 178-179, 2004 | 4 | 2004 |